Free Trial

AdaptHealth Corp. (NASDAQ:AHCO) Shares Bought by Nuveen Asset Management LLC

AdaptHealth logo with Medical background

Nuveen Asset Management LLC lifted its position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 27.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 316,108 shares of the company's stock after purchasing an additional 69,050 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.23% of AdaptHealth worth $3,009,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Assetmark Inc. acquired a new position in AdaptHealth in the fourth quarter valued at $28,000. Blue Trust Inc. grew its holdings in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after buying an additional 1,115 shares during the last quarter. Guggenheim Capital LLC grew its holdings in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after buying an additional 1,525 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in AdaptHealth in the 4th quarter valued at about $169,000. Finally, Humankind Investments LLC raised its stake in AdaptHealth by 18.3% during the 4th quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock valued at $171,000 after acquiring an additional 2,776 shares during the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Robert W. Baird lifted their target price on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. Truist Financial decreased their price target on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. UBS Group lowered their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Royal Bank of Canada cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research report on Thursday, May 8th. Finally, Canaccord Genuity Group raised their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $13.40.

Check Out Our Latest Analysis on AHCO

AdaptHealth Stock Performance

Shares of AHCO stock traded down $0.12 during trading hours on Friday, reaching $8.90. 693,674 shares of the company's stock were exchanged, compared to its average volume of 1,284,732. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The company's 50 day moving average is $8.79 and its two-hundred day moving average is $9.56. The company has a market cap of $1.20 billion, a P/E ratio of -5.39, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.90.

About AdaptHealth

(Free Report)

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Featured Stories

Institutional Ownership by Quarter for AdaptHealth (NASDAQ:AHCO)

Should You Invest $1,000 in AdaptHealth Right Now?

Before you consider AdaptHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.

While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double
The Next Palantir? AI-Defense Stock Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines